Lausten G S, Lemser T, Jensen P K, Egfjord M
Department of Orthopedics, Herlev Hospital, University of Copenhagen, Denmark.
Clin Transplant. 1998 Dec;12(6):572-4.
We reviewed the medical records of 750 patients (445 men, 305 women), who had received a kidney transplant during the period 1968-1995, for any sign of necrosis of the femoral head. For post-operative immunosuppression, 374 patients had received high-dose corticosteroids (average 12.5 g during the first year post-operatively), while 376 patients had received low-dose corticosteroids (average 6.5 g during the first year post-operatively) and cyclosporin A. Survival curves according to Kaplan and Meier (J Am Stat Ass 1958: 53: 457-481) were constructed. In the high-dose steroid group, 42/374 patients (11.2%) developed femoral head necrosis, at an average of 26.2 months post-transplantation. In the low-dose steroid group, only 19/376 (5.1%) patients developed this complication, at an average of 20.5 months post-transplantation. This difference in numbers of femoral head necroses was highly significant (p < 0.005). We conclude that steroid doses should be minimized whenever feasible in post-transplant immunosuppression therapy.
我们查阅了1968年至1995年间接受肾移植的750例患者(445例男性,305例女性)的病历,以寻找股骨头坏死的迹象。对于术后免疫抑制,374例患者接受了高剂量皮质类固醇(术后第一年平均12.5克),而376例患者接受了低剂量皮质类固醇(术后第一年平均6.5克)和环孢素A。根据Kaplan和Meier(《美国统计协会杂志》1958年:53:457 - 481)构建生存曲线。在高剂量类固醇组中,42/374例患者(11.2%)发生股骨头坏死,平均在移植后26.2个月。在低剂量类固醇组中,只有19/376例(5.1%)患者发生此并发症,平均在移植后20.5个月。股骨头坏死病例数的这种差异具有高度统计学意义(p < 0.005)。我们得出结论,在移植后免疫抑制治疗中,只要可行,应尽量减少类固醇剂量。